{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:03:08Z","timestamp":1790492588806,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1741,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.exphem.2017.05.007","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T09:45:13Z","timestamp":1496915113000},"page":"48-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia"],"prefix":"10.1016","volume":"53","author":[{"given":"Ivan","family":"Sloma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Mitjavila-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Feraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Griscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noufissa","family":"Oudrhiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaa","family":"El Marsafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Gobbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Divers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Proust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Smadja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Desterke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaick","family":"Carles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusanna","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hirst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie J.","family":"Eaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Bennaceur-Griscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G.","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2017.05.007_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/leu.2016.231","article-title":"Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy","volume":"31","author":"Chen","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.05.007_bib2","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI41246","article-title":"Chronic myeloid leukemia: Mechanisms of blastic transformation","volume":"120","author":"Perrotti","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2017.05.007_bib3","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1182\/blood-2011-10-385658","article-title":"Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors","volume":"119","author":"Nieborowska-Skorska","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.007_bib4","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1182\/blood-2012-11-466938","article-title":"Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells","volume":"121","author":"Bolton-Gillespie","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.007_bib5","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1182\/blood-2002-10-3011","article-title":"Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells","volume":"101","author":"Deutsch","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.007_bib6","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djk150","article-title":"Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells","volume":"99","author":"Jiang","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.exphem.2017.05.007_bib7","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.14694\/EdBook_AM.2015.35.e381","article-title":"Diagnosing and managing advanced chronic myeloid leukemia","author":"Deininger","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.exphem.2017.05.007_bib8","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/leu.2010.159","article-title":"Insights into the stem cells of chronic myeloid leukemia","volume":"24","author":"Sloma","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.05.007_bib9","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","volume":"21","author":"Jiang","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.05.007_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/leu.2010.298","article-title":"A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases","volume":"25","author":"Grossmann","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.05.007_bib11","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1182\/blood-2010-06-292433","article-title":"CBL, CBLB, TET2, ASXL1, and IDH1\/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia","volume":"117","author":"Makishima","year":"2011","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.exphem.2017.05.007_bib12","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.clml.2015.02.035","article-title":"Mutations in the BCR-ABL1 kinase domain and elsewhere in chronic myeloid leukemia","volume":"15","author":"Soverini","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.exphem.2017.05.007_bib13","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2017.05.007_bib14","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2017.05.007_bib15","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2017.05.007_bib16","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/leu.2011.139","article-title":"Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia","volume":"25","author":"Roche-Lestienne","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.05.007_bib17","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1038\/leu.2014.272","article-title":"Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status","volume":"28","author":"Schmidt","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.05.007_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood-2016-04-708560","article-title":"Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy","volume":"129","author":"Kim","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.007_bib19","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood-2016-06-723494","article-title":"Somatic mosaicism in chronic myeloid leukemia in remission","volume":"128","author":"Mitani","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.007_bib20","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2017.05.007_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature19823","article-title":"A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns","volume":"538","author":"Notta","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.05.007_bib22","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","article-title":"Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms","volume":"123","author":"Lundberg","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.007_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2017.05.007_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2014.12.028","article-title":"Cell lineage analysis in human brain using endogenous retroelements","volume":"85","author":"Evrony","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.exphem.2017.05.007_bib25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nature13448","article-title":"Genome sequencing of normal cells reveals developmental lineages and mutational processes","volume":"513","author":"Behjati","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.05.007_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-pathol-012615-044454","article-title":"Pathogenesis of myeloproliferative disorders","volume":"11","author":"Nangalia","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.exphem.2017.05.007_bib27","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.exphem.2017.05.007_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2017.05.007_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jcyt.2013.09.007","article-title":"Forearm ischemia decreases endothelial colony-forming cell angiogenic potential","volume":"16","author":"Mauge","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.exphem.2017.05.007_bib30","doi-asserted-by":"crossref","first-page":"e0149291","DOI":"10.1371\/journal.pone.0149291","article-title":"Donor dependent variations in hematopoietic differentiation among embryonic and induced pluripotent stem cell lines","volume":"11","author":"F\u00e9raud","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2017.05.007_bib31","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014A Europe Against Cancer program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.05.007_bib32","doi-asserted-by":"crossref","first-page":"35293","DOI":"10.18632\/oncotarget.9182","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation","volume":"7","author":"Chomel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.exphem.2017.05.007_bib33","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease","volume":"118","author":"Chomel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.007_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.05.007_bib35","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows\u2013Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.exphem.2017.05.007_bib36","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1101\/gr.137570.112","article-title":"Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer","volume":"22","author":"Ha","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.exphem.2017.05.007_bib37","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.exphem.2017.05.007_bib38","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/bioinformatics\/btq040","article-title":"SNVMix: Predicting single nucleotide variants from next-generation sequencing of tumors","volume":"26","author":"Goya","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.exphem.2017.05.007_bib39","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","article-title":"Strelka: Accurate somatic small-variant calling from sequenced tumor-normal sample pairs","volume":"28","author":"Saunders","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.exphem.2017.05.007_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.05.007_bib41","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ng.405","article-title":"Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II","volume":"41","author":"Schwarz","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2017.05.007_bib42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bjh.12302","article-title":"Oncogenic properties of sphingosine kinases in haematological malignancies","volume":"161","author":"Wallington-Beddoe","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2017.05.007_bib43","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","article-title":"The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors","volume":"117","author":"Nelson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.007_bib44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.exphem.2015.04.013","article-title":"The downregulation of BAP1 expression by BCR-ABL reduces the stability of BRCA1 in chronic myeloid leukemia","volume":"43","author":"Dkhissi","year":"2015","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2017.05.007_bib45","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-05-501072","article-title":"Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile","volume":"122","author":"Cramer-Morales","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.007_bib46","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.007_bib47","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2017.05.007_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia","volume":"107","author":"Johansson","year":"2002","journal-title":"Acta Haematol"},{"issue":"Suppl 1","key":"10.1016\/j.exphem.2017.05.007_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/10428199309047856","article-title":"The cytogenetic scenario of chronic myeloid leukemia","volume":"11","author":"Mitelman","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2017.05.007_bib50","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1038\/sj.onc.1202619","article-title":"Mutator phenotype of BCR\u2013ABL transfected Ba\/F3 cell lines and its association with enhanced expression of DNA polymerase beta","volume":"18","author":"Canitrot","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2017.05.007_bib51","doi-asserted-by":"crossref","first-page":"149ra18","DOI":"10.1126\/scitranslmed.3004315","article-title":"Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia","volume":"4","author":"Jan","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2017.05.007_bib52","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.05.007_bib53","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.05.007_bib54","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1387\/ijdb.103097mt","article-title":"Embryonic origin of human hematopoiesis","volume":"54","author":"Tavian","year":"2010","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.exphem.2017.05.007_bib55","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0140-6736(00)02241-8","article-title":"Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells","volume":"355","author":"Gunsilius","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2017.05.007_bib56","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2004-07-2514","article-title":"Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics","volume":"105","author":"Fang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.05.007_bib57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2141.2008.07195.x","article-title":"Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR\/ABL1 negative","volume":"142","author":"Otten","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2017.05.007_bib58","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.leukres.2015.05.014","article-title":"Do endothelial cells belong to the primitive stem leukemic clone in CML? Role of extracellular vesicles","volume":"39","author":"Ramos","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2017.05.007_bib59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.05.007_bib60","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1091\/mbc.02-01-0003","article-title":"Spindle checkpoint requires Mad1-bound and Mad1-free Mad2","volume":"13","author":"Chung","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.exphem.2017.05.007_bib61","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nrc1714","article-title":"On the road to cancer: Aneuploidy and the mitotic checkpoint","volume":"5","author":"Kops","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2017.05.007_bib62","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1038\/emboj.2011.239","article-title":"Probing the in\u00a0vivo function of Mad1:C-Mad2 in the spindle assembly checkpoint","volume":"30","author":"Fava","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2017.05.007_bib63","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1038\/sj.onc.1208589","article-title":"Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol","volume":"24","author":"Kienitz","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2017.05.007_bib64","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/jmg.2009.074252","article-title":"Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer","volume":"47","author":"Guo","year":"2010","journal-title":"J Med Genet"},{"issue":"18 Suppl","key":"10.1016\/j.exphem.2017.05.007_bib65","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1200\/jco.2006.24.18_suppl.5021","article-title":"Prognostic impact of MAD1L1 promoter hypermethylation in advanced ovarian cancer","volume":"24","author":"Jansen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.05.007_bib66","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1128\/MCB.16.10.5335","article-title":"RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas","volume":"16","author":"Thiagalingam","year":"1996","journal-title":"Mol Cell Biol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X17301923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X17301923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:27:58Z","timestamp":1654925278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X17301923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":66,"alternative-id":["S0301472X17301923"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2017.05.007","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2017.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}